Eastern Europe vs Naoero: Proportion of the target population who received 3 doses of
Eastern Europe
94.0%
in 2024
Naoero
99.0%
in 2024
Eastern Europe rank
2nd
Naoero rank
1st
Proportion of the target population who received 3 doses of over time
- Eastern Europe
- Naoero
How they compare
Naoero currently reports 99.0% against 94.0% in Eastern Europe, a difference of 5.0%.
That makes Naoero's figure about 1.1 times Eastern Europe's.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Eastern Europe ahead.
Eastern Europe ranks 2nd and Naoero ranks 1st of 37 groups.
Across the 3 decades both report, Eastern Europe averaged higher in 1 and Naoero in 2.
Head to head by decade
| Decade | Eastern Europe | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 82.8% | 14.2% | Eastern Europe |
| 2010s | 90.5% | 92.0% | 1.5% | Naoero |
| 2020s | 93.6% | 98.0% | 4.4% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, Eastern Europe or Naoero?
- Naoero, at 99.0% against 94.0% in Eastern Europe as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between Eastern Europe and Naoero?
- 5.0%, with Naoero ahead.
- How many years of comparable data are there for Eastern Europe and Naoero?
- 25 years are reported by both, from 2000 to 2024.
- How do Eastern Europe and Naoero rank globally for proportion of the target population who received 3 doses of?
- Eastern Europe ranks 2nd and Naoero ranks 1st of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.